Acquisition of 20 pseudoparticles (30ML each) for early translation branch (ETB) to support sars-COV-2 research for DPI_sars-COV-2_variant trace project
Ended Purchase Order Awarded Last action
- Contract number
- 75N95021P00484
- Awardee
-
Laboratories Nexelis Canada Inc. UEI MBEZLEGWHUN5 Part of Nexelis Group Inc.
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $204,000
Award facts
- Opportunity
-
- Acquisition of 20 Pseudoparticles (30mL each) for Early Translation Branch (ETB) to support SARS-CoV-2 research for DPI_SARS-CoV-2_Variant Trace Project Solicitation · 75N95021Q00439 · Posted Sep 17, 2021
- Contract value 100% obligated
- $204,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $204,000 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $204,000.00 firm fixed price purchase order to Laboratories Nexelis Canada Inc. (doing business as Pairimmune), a for-profit organization, to acquire 20 pseudoparticles (30ml each) to support SARS-CoV-2 research for the DPI_SARS-COV-2_VARIANT TRACE project. The award was not set aside and has a completion date of April 30, 2022. Nexelis Group Inc., the parent company of the awardee, is a self-certified small disadvantaged business.
Quick answers
Who was awarded contract 75N95021P00484?
75N95021P00484 was awarded to Laboratories Nexelis Canada Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 24, 2021.
How much is contract 75N95021P00484 worth?
The government has obligated $204,000 on 75N95021P00484.
Was contract 75N95021P00484 competed?
The extent of competition for 75N95021P00484 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award